Dong Sun

Prof. Dong Sun

Xuzhou Medical College Affiliated Hospital
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Life Sciences
Verified
Journal Article
Closed access
FGFang Gao
Fang Gao
BZBangjie Zuo
Bangjie Zuo
YWYanping Wang
Yanping Wang
SLShulin Li
Shulin Li
JYJianping Yang
Jianping Yang
DSDong Sun
Dong Sun

1 November 2021 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
YWYousuf Abdulkarim Waheed
Yousuf Abdulkarim Waheed
FYFan Yang
Fan Yang
DSDong Sun
Dong Sun
Previous research has investigated whether hyperuricemia serves as an independent risk factor for cardiovascular and renal diseases. Hyperuricemia is defined as an abnormally high level of uric acid (UA; i.e., serum urate level > 6.8 mg/dL). Hyperuricemia has been considered a complication of chronic kidney disease (CKD). However, it seems to play a pathogenic role in the progression of renal diseases. There has been increasing focus on the link between hyperuricemia and CKD. The results of randomized controlled trials have implied independent associations between hyperuricemia and the progression of cardiovascular and renal morbidities. These associations may be mediated by renin-angiotensin system activation, nitric oxide synthase inhibition, and macrovascular/microvascular disease development. There remains controversy regarding the use of serum UA level as an indirect index of renal vascular disease. This literature review focuses on the role of asymptomatic hyperuricemia in the progression of CKD, as well as the association between hyperuricemia and cardiovascular disease. It also provides a general overview of the physiological metabolism of UA.

17 May 2021 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
SLShulin Li
Shulin Li
FWFei Wang
Fei Wang
DSDong Sun
Dong Sun
Chronic kidney disease (CKD) affects 8–16% of the population worldwide and is characterized by fibrotic processes. Understanding the cellular and molecular mechanisms underpinning renal fibrosis is critical to the development of new therapeutics. Microvascular injury is considered an important contributor to renal progressive diseases. Vascular endothelium plays a significant role in responding to physical and chemical signals by generating factors that help maintain normal vascular tone, inhibit leukocyte adhesion and platelet aggregation, and suppress smooth muscle cell proliferation. Loss of the rich capillary network results in endothelial dysfunction, hypoxia, and inflammatory and oxidative effects and further leads to the imbalance of pro- and antiangiogenic factors, endothelial cell apoptosis and endothelial-mesenchymal transition. New techniques, including both invasive and noninvasive techniques, offer multiple methods to observe and monitor renal microcirculation and guide targeted therapeutic strategies. A better understanding of the role of endothelium in CKD will help in the development of effective interventions for renal microcirculation improvement. This review focuses on the role of microvascular injury in CKD, the methods to detect microvessels and the novel treatments to ameliorate renal fibrosis.

1 March 2019 in Life Sciences
Verified
Journal Article
Closed access
JLJie Liu
Jie Liu
SLShulin Li
Shulin Li
DSDong Sun
Dong Sun

28 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DSDong Sun
Dong Sun
LBLin Bu
Lin Bu
CLCaixia Liu
Caixia Liu
ZYZhongcheng Yin
Zhongcheng Yin
XZXudong Zhou
Xudong Zhou
AXAiguo Xiao
Aiguo Xiao
Interstitial fibrosis is regarded as the main pathway for the progression of chronic kidney disease (CKD) and is often associated with severe renal dysfunction. Stem cell-based therapies may provide alternative approaches for the treatment of CKD. Human amniotic fluid-derived stem cells (hAFSCs) are a novel stem cell population, which exhibit both embryonic and mesenchymal stem cell characteristics. Herein, the present study investigated whether the transplantation of hAFSCs into renal tissues could improve renal interstitial fibrosis in a murine model of unilateral ureteral obstruction (UUO). We showed that hAFSCs provided a protective effect and alleviated interstitial fibrosis as reflected by an increase in microvascular density; additionally, hAFSCs treatment beneficially modulated protein levels of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1α (HIF-1α) and transforming growth factor-β1 (TGF-β1). Therefore, we hypothesize that hAFSCs could represent an alternative, readily available source of stem cells that can be applied for the treatment of renal interstitial fibrosis.

28 March 2019 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
SLShulin Li
Shulin Li
YWYanping Wang
Yanping Wang
LCLu Chen
Lu Chen
ZWZhuojun Wang
Zhuojun Wang
GLGuodong Liu
Guodong Liu
DSDong Sun
Dong Sun